Showing results (1311-1320 of 5,347) with videos related to

Sort By:
Pageof 535
Japanese Journal of Clinical Oncology|December 1, 1992
Cardiac tamponade in chronic myelomonocytic leukemia: a case reportY Yufu, Y Okada, T Goto, et al.
Japanese Journal of Clinical Oncology|February 12, 2011
Regimen selection for first-line FOLFIRI and FOLFOX based on UGT1A1 genotype and physical background is feasible in Japanese patients with advanced colorectal cancerHiroo Ishida, Ken-Ichi Fujita, Yuko Akiyama, et al.
Japanese Journal of Clinical Oncology|January 21, 2011
Melphalan-prednisolone and vincristine-doxorubicin-dexamethasone chemotherapy followed by prednisolone/interferon maintenance therapy for multiple myeloma: Japan Clinical Oncology Group Study, JCOG0112Takaaki Chou, Kensei Tobinai, Naokuni Uike, et al.
Japanese Journal of Clinical Oncology|February 10, 2011
Interstitial lung disease during chemotherapy combined with oxaliplatin and/or bevacizumab in advanced colorectal cancer patientsKazuhiro Usui, Yuu Katou, Kaoru Furushima, et al.
Japanese Journal of Clinical Oncology|January 15, 2011
Ki67 and BUBR1 may discriminate clinically insignificant prostate cancer in the PSA range <4 ng/mlKazuhiro Nagao, Yoshiaki Yamamoto, Tomohiko Hara, et al.
Japanese Journal of Clinical Oncology|January 15, 2011
Tertiary Gleason pattern 5 and oncological outcomes after radical prostatectomyKatsuyoshi Hashine, Akihito Yuasa, Kensuke Shinomori, et al.
Japanese Journal of Clinical Oncology|September 8, 2010
Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) projectTomohiro Matsuda, Tomomi Marugame, Ken-ichi Kamo, et al.
Japanese Journal of Clinical Oncology|October 8, 2010
Metastatic hepatocellular carcinoma in the tympanic membraneZong-Sin Wu, Szu-Chin Li, Hsu-Chueh Ho, et al.
Japanese Journal of Clinical Oncology|October 8, 2010
Two consecutive cases of platinum-refractory pulmonary pleomorphic carcinoma that showed dramatic responses to MAID (mesna, doxorubicin, ifosfamide and dacarbazine) chemotherapyKeun-Wook Lee, Yu Jung Kim, Jee Hyun Kim, et al.
Japanese Journal of Clinical Oncology|October 8, 2010
The importance of evaluation of DNA amplificability in KRAS mutation testing with dideoxy sequencing using formalin-fixed and paraffin-embedded colorectal cancer tissuesNaoko Okayama, Mitsuaki Nishioka, Shoichi Hazama, et al.
Pageof 535